New England
Educational Institute
A Leader in Continuing Education
for Mental Health Professionals
Cape Cod, Massachusetts
Santa Fe, NM
Marco Island, FL
Ireland with Thomas Moore

New England
Educational Institute

learn@neei.org

phone 413-499-1489
fax 413-499-6584

449 Pittsfield Rd
Suite 201
Lenox, MA 01240

34th Annual Cape Cod Symposia

Clinical Psychopharmacology: Overview and Recent Advances

- Ross Baldessarini, M.D.
July 31 - August 4, 2017, Cape Cod, MA

Program & Presenter

Ross Baldessarini, M.D., is Professor of Psychiatry and in Neuroscience at Harvard Medical School and Director Emeritus of the Psychopharmacology Program and Director of the International Consortium for Psychotic and Bipolar Disorders at McLean Hospital. Dr. Baldessarini is known for his research and teaching in psychopharmacology and general psychiatry. He is the author of over 2,200 scientific papers and several books, including Chemotherapy in Psychiatry: Principles and Practice, 3rd edition (2013), and for many years the chapters on psychopharmaology in the standard textbook of pharmacology, Goodman & Gilman’s The Pharmacological Basis of Therapeutics. He has served on many editorial boards, including that of the American Journal of Psychiatry and JAMA Psychiatry. For his exceptional teaching skills, Dr. Baldessarini was awarded the first prestigious NEEI Mental Health Educator of the Year award.

Symposium Description

Dr. Baldessarini’s symposium will review the current status of psychotropic drug treatment of psychotic and major mood disorders, with an emphasis on the research base on which sound clinical practice rests. Participants will learn an integration of research findings and relate these to principles of informed clinical decision-making so as to enhance treatment effectiveness and safety. Participants will learn an updated view of the chemical nature of agents in each class, their major actions, and disposition, short- and long-term clinical treatment, including applications in pediatric and geriatric practice, risks of adverse effects, and emerging advances in new and experimental treatments.

Symposium Schedule

Monday

  • Introduction to psychopharmacology: History and current trends/ Introduction to antipsychotic agents: Their neurobiological action mechanisms and pharmacokinetics/ Clinical indications for antipsychotic drugs/ Questions and discussion

Tuesday

  • Short-term management of treatment and dosing of antipsychotics/ Comparative efficacy among antipsychotic drugs/ Long-term indications, effectiveness and risks of antipsychotics/ Questions and discussion

Wednesday

  • Mood-stabilizing agents: Lithium, anticonvulsants, antipsychotics, and others/ Short-term management of acute manic-depressive phases of bipolar disorder/ Long-term prophylaxis for bipolar disorder/ Assessment and management of adverse effects of mood-stabilizers/ Questions and discussion

Thursday

  • First- and second-generation antidepressants/ Their neurobiological action mechanisms/ Pharmacokinetics and blood levels/ Clinical indications for antidepressants in mood, anxiety, and other disorders/ Short-term efficacy and long-term effectiveness of antidepressant treatment/ Adverse effects of antidepressants/Questions and discussion

Friday

  • Pharmacology of suicide and other mortality in psychiatric patients/ Enhancing long-term treatment-adherence through a “consumer’s” perspective/ Integration of pharmacotherapy with comprehensive care of patients/ Open discussion
Feedback